{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=warfarin+tablets&page=2", "query": { "intervention": "warfarin tablets", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=warfarin+tablets&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T07:04:00.095Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07838987", "title": "A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "TERN-701", "type": "DRUG" }, { "name": "Rabeprazole", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Digoxin", "type": "DRUG" }, { "name": "Pravastatin", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Bosentan", "type": "DRUG" }, { "name": "Quinidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 196, "start_date": "2023-12-21", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 1, "location_summary": "Millcreek, Utah", "locations": [ { "city": "Millcreek", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07838987" }, { "nct_id": "NCT00329238", "title": "Secondary Prevention of Venous Thrombo Embolism (VTE).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Thromboembolism" ], "interventions": [ { "name": "Dabigatran", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2867, "start_date": "2006-05", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-19", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 18, "location_summary": "Mobile, Alabama • Hartford, Connecticut • Clearwater, Florida + 15 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00329238" }, { "nct_id": "NCT00403767", "title": "An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation", "Stroke", "Embolism" ], "interventions": [ { "name": "Rivaroxaban", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Matching placebo for Rivaroxaban arm (Warfarin placebo)", "type": "DRUG" }, { "name": "Matching placebo for Warfarin arm (Rivaroxaban placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14269, "start_date": "2006-12", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2014-04-29", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 295, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Geneva, Alabama + 292 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Geneva", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Pell City", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00403767" }, { "nct_id": "NCT04254783", "title": "A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ulcerative Colitis (UC)", "Crohn's Disease" ], "interventions": [ { "name": "Risankizumab", "type": "DRUG" }, { "name": "Cytochrome P450 (CYP) Substrates", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2020-05-27", "completion_date": "2022-10-14", "has_results": false, "last_update_posted_date": "2024-07-01", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 4, "location_summary": "Coronado, California • DeLand, Florida • Margate, Florida + 1 more", "locations": [ { "city": "Coronado", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Margate", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04254783" }, { "nct_id": "NCT00487136", "title": "Interaction Between ABT-335, Rosuvastatin and Warfarin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Warfarin", "type": "DRUG" }, { "name": "warfarin plus ABT-335 plus rosuvastatin 5 mg", "type": "DRUG" }, { "name": "warfarin plus ABT-335 plus rosuvastatin 20 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 45, "start_date": "2007-06", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2012-09-28", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00487136" }, { "nct_id": "NCT06215430", "title": "A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Caffeine Tablet", "type": "DRUG" }, { "name": "Omeprazole capsule", "type": "DRUG" }, { "name": "Warfarin tablet", "type": "DRUG" }, { "name": "Pirtobrutinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 16, "start_date": "2021-01-11", "completion_date": "2021-04-15", "has_results": true, "last_update_posted_date": "2025-03-10", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06215430" }, { "nct_id": "NCT00404274", "title": "A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nausea and Vomiting, Chemotherapy-Induced" ], "interventions": [ { "name": "Casopitant (GW679769) oral tablets", "type": "DRUG" }, { "name": "Warfarin oral tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 97, "start_date": "2006-11-01", "completion_date": "2007-03-18", "has_results": false, "last_update_posted_date": "2017-08-09", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 2, "location_summary": "Gainesville, Florida • Buffalo, New York", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00404274" }, { "nct_id": "NCT00986154", "title": "Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thromboembolism", "Deep Vein Thrombosis (DVT)", "Pulmonary Embolism (PE)", "Thromboembolism", "Venous Thrombosis" ], "interventions": [ { "name": "edoxaban tosylate(DU-176b)", "type": "DRUG" }, { "name": "low molecular weight heparin/unfractionated heparin", "type": "DRUG" }, { "name": "warfarin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8292, "start_date": "2009-10", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2019-03-05", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 82, "location_summary": "Mobile, Alabama • Montgomery, Alabama • Phoenix, Arizona + 71 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00986154" }, { "nct_id": "NCT00904176", "title": "Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Digoxin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 30, "start_date": "2009-06", "completion_date": "2009-08", "has_results": false, "last_update_posted_date": "2016-10-17", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 1, "location_summary": "Lenexa, Kansas", "locations": [ { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00904176" }, { "nct_id": "NCT05891119", "title": "Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Caffeine", "type": "DIETARY_SUPPLEMENT" }, { "name": "Metoprolol", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Vitamin K", "type": "DIETARY_SUPPLEMENT" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "Rocatinlimab", "type": "DRUG" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 21, "start_date": "2023-06-03", "completion_date": "2025-02-12", "has_results": false, "last_update_posted_date": "2025-12-23", "last_synced_at": "2026-09-26T07:04:00.095Z", "location_count": 7, "location_summary": "North Hollywood, California • DeLand, Florida • Hialeah, Florida + 4 more", "locations": [ { "city": "North Hollywood", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Dilworth", "state": "Minnesota" }, { "city": "Camp Hill", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05891119" } ] }